Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19
- DOI
- 10.1038/s41598-022-10890-w
- Published
- 2022-04-19
- Container
- Scientific Reports
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-022-10890-w,
title = {Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19},
author = {Xiyuan Bai and Ashley M. Buckle and Eszter K. Vladar and Edward N. Janoff and Reeti Khare and Diane Ordway and David Beckham and Lorelenn B. Fornis and Abraham Majluf-Cruz and Randolph V. Fugit and Brian M. Freed and Soohyun Kim and Robert A. Sandhaus and Edward D. Chan},
year = {2022},
journal = {Scientific Reports},
doi = {10.1038/s41598-022-10890-w},
url = {https://doi.org/10.1038/s41598-022-10890-w}
}RIS
TY - JOUR TI - Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 AU - Xiyuan Bai AU - Ashley M. Buckle AU - Eszter K. Vladar AU - Edward N. Janoff AU - Reeti Khare AU - Diane Ordway AU - David Beckham AU - Lorelenn B. Fornis AU - Abraham Majluf-Cruz AU - Randolph V. Fugit AU - Brian M. Freed AU - Soohyun Kim AU - Robert A. Sandhaus AU - Edward D. Chan PY - 2022 JO - Scientific Reports DO - 10.1038/s41598-022-10890-w UR - https://doi.org/10.1038/s41598-022-10890-w ER -
APA
Bai, X., Buckle, A. M., Vladar, E. K., Janoff, E. N., Khare, R., Ordway, D., Beckham, D., Fornis, L. B., Majluf-Cruz, A., Fugit, R. V., Freed, B. M., Kim, S., Sandhaus, R. A., & Chan, E. D. (2022). Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. Scientific Reports. https://doi.org/10.1038/s41598-022-10890-w
Source records
- crossref · retrieved 2026-09-26T03:57:32.414Z